NEXUS IB10 Trademark

Trademark Overview

On Thursday, July 12, 2018, a trademark application was filed for NEXUS IB10 with the United States Patent and Trademark Office. The USPTO has given the NEXUS IB10 trademark a serial number of 88035770. The federal status of this trademark filing is REGISTERED as of Tuesday, September 29, 2020. This trademark is owned by Nexus-Dx, Inc.. The NEXUS IB10 trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, analyzers for assay tests; Immunoassay analyzers for medical diagnostic uses; In vitro immunology analyzers for medical purposes that measure whole blood and plasma
nexus ib10

General Information

Serial Number88035770
Word MarkNEXUS IB10
Filing DateThursday, July 12, 2018
Status700 - REGISTERED
Status DateTuesday, September 29, 2020
Registration Number6164629
Registration DateTuesday, September 29, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and ServicesMedical devices, namely, analyzers for assay tests; Immunoassay analyzers for medical diagnostic uses; In vitro immunology analyzers for medical purposes that measure whole blood and plasma
Pseudo MarkNEXUS IB TEN

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 17, 2018
Primary Code010
First Use Anywhere DateMonday, July 8, 2019
First Use In Commerce DateMonday, July 8, 2019

Trademark Owner History

Party NameNexus-Dx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameNexus-Dx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameNexus-Dx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, September 29, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, August 26, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 25, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2020NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, March 26, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, March 9, 2020USE AMENDMENT FILED
Thursday, March 26, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 9, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2020EXTENSION 1 GRANTED
Thursday, February 27, 2020EXTENSION 1 FILED
Thursday, February 27, 2020TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 15, 2019ASSIGNED TO LIE
Wednesday, May 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 16, 2018NON-FINAL ACTION E-MAILED
Friday, November 16, 2018NON-FINAL ACTION WRITTEN
Tuesday, October 30, 2018ASSIGNED TO EXAMINER
Tuesday, July 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 16, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

nexus analyzers medical purposes immunology measure whole plasma blood vitro diagnostic